Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Sigma‐1 and Sigma‐2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patterns
Radioligand binding assay conditions were established for the selective labeling of sigma‐1 and sigma‐2 sites in membrane homogenates of rat brain. Selective sigma‐1 assays were conducted using 5 nM… Expand
Medication Nonadherence, “Professional Subjects,” and Apparent Placebo Responders: Overlapping Challenges for Medications Development
- D. McCann, N. Petry, Anders Bresell, Eva Isacsson, E. Wilson, R. Alexander
- Journal of clinical psychopharmacology
- 1 October 2015
Abstract Nonadherence is a major problem in clinical trials of new medications. To evaluate the extent of nonadherence, this study evaluated pharmacokinetic sampling from 1765 subjects receiving… Expand
Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions.
The distribution of haloperidol-sensitive (+)[3H]N-allylnormetazocine ((+)[3H]SKF-10,047) binding sites (sigma sites) in subcellular fractions of rat brain homogenates was extensively characterized.… Expand
Drugs of abuse: management of intoxication and antidotes.
Illicit drug intoxications are an increasing public health problem for which, in most cases, no antidotes are clinically available. The diagnosis and treatment of these intoxications requires a… Expand
Phencyclidine/SKF-10,047 binding sites: Evaluation of function
- D. McCann, R. Rabin, S. Rens-Domiano, J. C. Winter
- Medicine, Chemistry
- Pharmacology Biochemistry and Behavior
- 31 January 1989
Results of correlation analyses comparing rank-order affinities with rank-order potencies of (+)SKF-10,047, phencyclidine (PCP), and several PCP analogs support the involvement of… Expand
Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes.
The zwitterionic detergent 3-[(3-cholamidopropyl)dimethylamino]-1-propanesulfonate (CHAPS) produced optimal solubilization of (+)-[3H]SKF-10,047 binding sites from rat liver membranes at a… Expand
Mitigating the Effects of Nonadherence in Clinical Trials
- T. Shiovitz, E. Bain, +4 authors Daniel J. Burch
- Journal of clinical pharmacology
- 22 January 2016
Accounting for subject nonadherence and eliminating inappropriate subjects in clinical trials are critical elements of a successful study. Nonadherence can increase variance, lower study power, and… Expand
Potential of Buprenorphine/Naltrexone in Treating Polydrug Addiction and Co‐occurring Psychiatric Disorders
- D. McCann
- Clinical pharmacology and therapeutics
- 1 April 2008
In recent years, we have seen regulatory approval being given for several new pharmacotherapies in the treatment of drug addiction disorders. Within the United States, the most noteworthy development… Expand
Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys.
- C. W. Schindler, J. P. Gilman, L. Panlilio, D. McCann, S. Goldberg
- Psychology, Medicine
- Experimental and clinical psychopharmacology
- 1 February 2011
The effectiveness of methadone as a treatment for opioid abuse and nicotine preparations as treatments for tobacco smoking has led to an interest in developing a similar strategy for treating… Expand
Interactions of clonidine with phencyclidine and ketamine: Studies of radial maze performance and righting reflex in rats
Rats were trained to obtain food pellets in an 8-arm radial maze until a criterion of 89% efficiency, i.e., all arms entered within 9 arm entries, was reached in 5 consecutive sessions. Decreases in… Expand